164 related articles for article (PubMed ID: 9124827)
1. In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae.
Sorensen KN; Kim KH; Takemoto JY
Antimicrob Agents Chemother; 1996 Dec; 40(12):2710-3. PubMed ID: 9124827
[TBL] [Abstract][Full Text] [Related]
2. A new syringopeptin produced by bean strains of Pseudomonas syringae pv. syringae.
Grgurina I; Mariotti F; Fogliano V; Gallo M; Scaloni A; Iacobellis NS; Lo Cantore P; Mannina L; van Axel Castelli V; Greco ML; Graniti A
Biochim Biophys Acta; 2002 May; 1597(1):81-9. PubMed ID: 12009406
[TBL] [Abstract][Full Text] [Related]
3. Relevance of chlorine-substituent for the antifungal activity of syringomycin and syringotoxin, metabolites of the phytopathogenic bacterium Pseudomonas syringae pv. syringae.
Grgurina I; Barca A; Cervigni S; Gallo M; Scaloni A; Pucci P
Experientia; 1994 Feb; 50(2):130-3. PubMed ID: 8125171
[TBL] [Abstract][Full Text] [Related]
4. [Activity of toxins produced by Pseudomonas syringae pv. syringae in model and cell membranes].
Gur'nev FA; Kaulin IuA; Tikhomirova AV; Wangspa R; Takemoto D; Malev VV; Shchagina LV
Tsitologiia; 2002; 44(3):296-304. PubMed ID: 12094768
[TBL] [Abstract][Full Text] [Related]
5. PCR Detection of Cyclic Lipodepsinonapeptide-Producing Pseudomonas syringae pv. syringae and Similarity of Strains.
Sorensen KN; Kim KH; Takemoto JY
Appl Environ Microbiol; 1998 Jan; 64(1):226-30. PubMed ID: 16349482
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.
Bartizal K; Scott T; Abruzzo GK; Gill CJ; Pacholok C; Lynch L; Kropp H
Antimicrob Agents Chemother; 1995 May; 39(5):1070-6. PubMed ID: 7625791
[TBL] [Abstract][Full Text] [Related]
7. Yeast genes involved in growth inhibition by Pseudomonas syringae pv. syringae syringomycin family lipodepsipeptides.
Takemoto JY; Yu Y; Stock SD; Miyakawa T
FEMS Microbiol Lett; 1993 Dec; 114(3):339-42. PubMed ID: 8288110
[TBL] [Abstract][Full Text] [Related]
8. Preliminary description of biocidal (syringomycin) activity in fluorescent plant pathogenic Pseudomonas species.
Hu FP; Young JM; Fletcher MJ
J Appl Microbiol; 1998 Aug; 85(2):365-71. PubMed ID: 9750309
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
[TBL] [Abstract][Full Text] [Related]
10. From bacteria: a new weapon against fungal infection.
Potera C
Science; 1994 Jul; 265(5172):605. PubMed ID: 8036509
[No Abstract] [Full Text] [Related]
11. Fungicidal Activities and Mechanisms of Action of Pseudomonas syringae pv. syringae Lipodepsipeptide Syringopeptins 22A and 25A.
Bensaci MF; Gurnev PA; Bezrukov SM; Takemoto JY
Front Microbiol; 2011; 2():216. PubMed ID: 22046175
[TBL] [Abstract][Full Text] [Related]
12. Syringomycin production among strains of Pseudomonas syringae pv. syringae: conservation of the syrB and syrD genes and activation of phytotoxin production by plant signal molecules.
Quigley NB; Gross DC
Mol Plant Microbe Interact; 1994; 7(1):78-90. PubMed ID: 7909458
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
14. The interaction of lipodepsipeptide toxins from Pseudomonas syringae pv. syringae with biological and model membranes: a comparison of syringotoxin, syringomycin, and two syringopeptins.
Dalla Serra M; Fagiuoli G; Nordera P; Bernhart I; Della Volpe C; Di Giorgio D; Ballio A; Menestrina G
Mol Plant Microbe Interact; 1999 May; 12(5):391-400. PubMed ID: 10226372
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of lipodepsipeptides produced by Pseudomonas syringae pv syringae B359.
Buber E; Stindl A; Acan NL; Kocagoz T; Zocher R
Nat Prod Lett; 2002 Dec; 16(6):419-23. PubMed ID: 12462348
[TBL] [Abstract][Full Text] [Related]
16. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
17. Requirement of sphingolipid alpha-hydroxylation for fungicidal action of syringomycin E.
Hama H; Young DA; Radding JA; Ma D; Tang J; Stock SD; Takemoto JY
FEBS Lett; 2000 Jul; 478(1-2):26-8. PubMed ID: 10922463
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
Pfaller MA; Marco F; Messer SA; Jones RN
Diagn Microbiol Infect Dis; 1998 Apr; 30(4):251-5. PubMed ID: 9582584
[TBL] [Abstract][Full Text] [Related]
19. Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity.
Harrison L; Teplow DB; Rinaldi M; Strobel G
J Gen Microbiol; 1991 Dec; 137(12):2857-65. PubMed ID: 1791440
[TBL] [Abstract][Full Text] [Related]
20. Role of ergosterol in growth inhibition of Saccharomyces cerevisiae by syringomycin E.
Wangspa R; Takemoto JY
FEMS Microbiol Lett; 1998 Oct; 167(2):215-20. PubMed ID: 9809422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
